1. Candidate biomarkers in psychiatric disorders: state of the field;Abi-Dargham;World Psych,2023
2. Anon. European Medicines Agency, 2014. Qualification of novel methodologies for medicine development.
3. Anon. U.S. Food and Drug Administration, 2016. FDA-NIH biomarker working group. best (biomarkers, endpoints, and other tools) resource.
4. Anon. U.S. Food and Drug Administration, 2018. Biomarker qualification: evidentiary framework; draft guidance for industry and FDA staff.
5. Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010;Agid;Am. J. Psych,2013